日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Tet methylcytosine dioxygenase 2 (TET2) deficiency elicits EGFR-TKI (tyrosine kinase inhibitors) resistance in non-small cell lung cancer

四甲基胞嘧啶双加氧酶 2 (TET2) 缺乏导致非小细胞肺癌产生 EGFR-TKI(酪氨酸激酶抑制剂)耐药

Jian Zhang #, Kejia Zhao #, Wenjing Zhou, Ran Kang, Shiyou Wei, Yueli Shu, Cheng Yu, Yin Ku, Yonghong Mao, Hao Luo, Juqin Yang, Jiandong Mei, Qiang Pu, Senyi Deng, Zhengyu Zha, Gang Yuan, Shensi Shen, Yaohui Chen, Lunxu Liu

Multicellular ecotypes shape progression of lung adenocarcinoma from ground-glass opacity toward advanced stages

多细胞生态型影响肺腺癌从磨玻璃样混浊发展到晚期的过程

Yulan Deng ,Liang Xia ,Jian Zhang ,Senyi Deng ,Mengyao Wang ,Shiyou Wei ,Kaixiu Li ,Hongjin Lai ,Yunhao Yang ,Yuquan Bai ,Yongcheng Liu ,Lanzhi Luo ,Zhenyu Yang ,Yaohui Chen ,Ran Kang ,Fanyi Gan ,Qiang Pu ,Jiandong Mei ,Lin Ma ,Feng Lin ,Chenglin Guo ,Hu Liao ,Yunke Zhu ,Zheng Liu ,Chengwu Liu ,Yang Hu ,Yong Yuan ,Zhengyu Zha ,Gang Yuan ,Gao Zhang ,Luonan Chen ,Qing Cheng ,Shensi Shen ,Lunxu Liu

Development of a Prognostic Risk Model for Esophageal Cancer Based on M0 Macrophage-Related Genes

基于M0巨噬细胞相关基因的食管癌预后风险模型的建立

Xiaoping Zuo #, Fuqiang Wang #, Guofeng Liu #, Shenglong Xie, Senyi Deng, Yun Wang

Dual network analysis of transcriptome data for discovery of new therapeutic targets in non-small cell lung cancer

转录组数据的双网络分析用于发现非小细胞肺癌的新治疗靶点

Yuquan Bai, Lu Zhou, Chuanfen Zhang, Minzhang Guo, Liang Xia, Zhenying Tang, Yi Liu, Senyi Deng

Metformin attenuates chronic lung allograft dysfunction: evidence in rat models

二甲双胍减轻慢性肺移植功能障碍:大鼠模型中的证据

Dong Tian #, Xiangyun Zheng #, Hongtao Tang, Heng Huang, Junjie Wang, Lin Xu, Caihan Li, Haoji Yan, Ruixuan Yu, Jinzhu Nan, Menggen Liu, Xiaoguang Guo, Shunhai Jian, Tao Wang, Senyi Deng, Qiang Pu, Lunxu Liu0

Identification of GPX4 as a therapeutic target for lung adenocarcinoma after EGFR-TKI resistance

确定 GPX4 为 EGFR-TKI 耐药后肺腺癌的治疗靶点

Chuanfen Zhang, Chunmei Wang, Zhenyu Yang, Yuquan Bai, Takehito Shukuya, Mau-Ern Poh, Simon Ekman, Jian Li, Yuyang Xu, Senyi Deng

Targeting STT3A produces an anti-tumor effect in lung adenocarcinoma by blocking the MAPK and PI3K/AKT signaling pathway

靶向STT3A可通过阻断MAPK和PI3K/AKT信号通路,在肺腺癌中产生抗肿瘤作用。

Jiahan Cheng #,Liang Xia #,Xiaohu Hao #,Fanyi Gan,Yuquan Bai,Chuanfen Zhang,Yonghong Mao,Yunke Zhu,Qiang Pu,Dong Won Park,Simona Tavolari,Jiandong Mei,Yaohui Chen,Senyi Deng,Lunxu Liu

Identifies Immune Feature Genes for Prediction of Chemotherapy Benefit in Cancer

识别免疫特征基因以预测癌症化疗的益处

Yuquan Bai, Chuan Li, Liang Xia, Fanyi Gan, Zhen Zeng, Chuanfen Zhang, Yulan Deng, Yuyang Xu, Chengwu Liu, Senyi Deng, Lunxu Liu

Tumor-endogenous PD-1 promotes cell proliferation and predicts poor survival in non-small cell lung cancer

肿瘤内源性 PD-1 促进细胞增殖并预测非小细胞肺癌生存率低

Fanyi Gan #, Chuanfen Zhang #, Liang Xia, Senyi Deng

Identifying the prognostic significance of B3GNT3 with PD-L1 expression in lung adenocarcinoma

确定 B3GNT3 与 PD-L1 表达在肺腺癌中的预后意义

Xuefeng Leng, Shiyou Wei, Jiandong Mei, Senyi Deng, Zhenyu Yang, Zheng Liu, Chenglin Guo, Yulan Deng, Liang Xia, Jiahan Cheng, Kejia Zhao, Fanyi Gan, Chuan Li, Kenneth W Merrell, Julian R Molina, Giulio Metro, Lunxu Liu